Skip to main
CNC

Centene (CNC) Stock Forecast & Price Target

Centene (CNC) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 7%
Buy 20%
Hold 60%
Sell 7%
Strong Sell 7%

Bulls say

Centene's improved medical loss ratio (MLR) of 93.4% in 3Q25 reflects a year-over-year enhancement and a sequential increase of approximately 150 basis points, indicating better cost management in its Medicaid segment, which comprises 64% of its membership. The company anticipates a composite rate improvement of around 5.5%, with notable visibility into half of the 1/1 rates, bolstering expectations for revenue consistency. Additionally, the growth in 3.5+ Star plans, reaching 60% membership, suggests strengthened quality performance metrics that may enhance competitive positioning and revenue opportunities.

Bears say

Centene's reliance on government-sponsored healthcare plans, particularly in the Medicaid sector, subjects it to significant risks associated with adverse regulatory changes and escalating utilization rates. The company anticipates a decrease in its high-cost Silver positions, indicating potential challenges in maintaining profitability as competition in the marketplace increases. Additionally, factors such as deteriorating risk scores and pressures on Medicaid margins contribute to a negative outlook for Centene's financial performance moving forward.

Centene (CNC) has been analyzed by 15 analysts, with a consensus rating of Hold. 7% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 7% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of Centene and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Centene (CNC) Forecast

Analysts have given Centene (CNC) a Hold based on their latest research and market trends.

According to 15 analysts, Centene (CNC) has a Hold consensus rating as of Apr 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Centene (CNC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.